Os Therapies Incorporated Stock Investor Sentiment

OSTX Stock   1.97  0.26  11.66%   
Slightly above 64% of OS Therapies' investor base is looking to short. The analysis of the overall investor sentiment regarding OS Therapies Incorporated suggests that many traders are alarmed. OS Therapies' investing sentiment can be driven by a variety of factors including economic data, OS Therapies' earnings reports, geopolitical events, and overall market trends.
  
few days ago at benzinga.com         
Disposition of 100000 shares by Auerbach Shalom of OS Therapies at 2.843 subject to Rule 16b-3
benzinga news
over a week ago at news.google.com         
OS Therapies Provides Corporate Update - StockTitan
Google News at Macroaxis
over two weeks ago at seekingalpha.com         
OS Therapies announces offering of 10.83M shares by selling stockholders
seekingalpha News
over two weeks ago at news.google.com         
OS Therapies Earns Buy Rating from D. Boral Capital - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
OS Therapies Incorporated agreed to acquire Immuno-Oncology Programs and IP Assets from Ayala Pharma...
Google News at Macroaxis
over two weeks ago at news.google.com         
OS Therapies to Acquire Certain Ayala Pharmaceuticals Assets -January 29, 2025 at 1058 am EST - Mark...
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over two weeks ago at thelincolnianonline.com         
OS Therapies Incs Lock-Up Period Set To Expire Tomorrow
news
over three weeks ago at news.google.com         
OS Therapies Incs Lock-Up Period Set To Expire on January 28th - MarketBeat
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
OS Therapies Given New 15.00 Price Target at Maxim Group
news
over a month ago at thelincolnianonline.com         
OS Therapies Completes Private Placement with Gross Proceeds of 7.1 Million
news
over a month ago at news.google.com         
OS Therapies A Cheap Mid-Stage Biotech Carrying Listeria-Based Immunotherapy - Seeking Alpha
Google News at Macroaxis
over a month ago at benzinga.com         
Why Is Pediatric-Cancer Focused OS Therapies Stock Trading Higher On Wednesday?
benzinga news
over a month ago at benzinga.com         
Disposition of 16720 shares by Auerbach Shalom of OS Therapies at 6.735 subject to Rule 16b-3
benzinga news
over a month ago at news.google.com         
OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about OS Therapies that are available to investors today. That information is available publicly through OSTX media outlets and privately through word of mouth or via OSTX internal channels. However, regardless of the origin, that massive amount of OSTX data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of OS Therapies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of OS Therapies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to OS Therapies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive OS Therapies alpha.

OS Therapies Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.151234567Dec2025Feb -40-20020406080
JavaScript chart by amCharts 3.21.15OS Therapies OS Therapies Dividend Benchmark Dow Jones Industrial
       Timeline  
1
OS Therapies Shares Up 35.3 percent - Heres What Happened - MarketBeat
12/18/2024
2
OS Therapies Announces Closing of 6 Million Private Placement - Business Wire
12/31/2024
3
Why Is Pediatric-Cancer Focused OS Therapies Stock Trading Higher On Wednesday
01/15/2025
4
OS Therapies Given New 15.00 Price Target at Maxim Group
01/17/2025
5
Insider Trading
01/28/2025
6
OS Therapies Earns Buy Rating from D. Boral Capital - MarketBeat
01/31/2025
7
Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer
02/14/2025

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…